Insider Transactions Reported by 18 Insiders of RIGEL PHARMACEUTICALS INC

Symbol
RIGL on Nasdaq
Location
South San Francisco, CA

There are no Buy or Sell transactions made by insiders since 11 Feb 2025

RIGEL PHARMACEUTICALS INC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
RAUL R. RODRIGUEZ CEO, President, Director $8,487,881 26 Jan 2026
Dean L. Schorno EVP & Chief Financial Officer $2,133,484 02 Feb 2026
David A. Santos EVP, Chief Commercial Officer $1,691,965 02 Feb 2026
Raymond Furey EVP, GC, CCO & Corp Sec $1,291,390 02 Feb 2026
Lisa Rojkjaer EVP, Chief Medical Officer $437,126 15 Sep 2025
WALTER H. MOOS Director $242,481 23 May 2025
Jane Wasman Director $238,250 23 May 2025
Gregg A. Lapointe Director $238,250 23 May 2025
ALISON L. HANNAH Director $202,512 23 May 2025
Kamil Ali-Jackson Director $178,687 23 May 2025
GARY A. LYONS Director $131,250 26 May 2023
Wolfgang Dummer Evp & Cmo $126,803 02 Feb 2023
Brian L. Kotzin Director $114,000 25 May 2024
Dolly Vance EVP Corp. Affairs, G.C., Sect. $105,455 14 Sep 2022
Bradford S. Goodwin Director $61,250 19 May 2021
Keith Katkin Director $43,750 19 May 2021
Mark W. Frohlich Director $23,825 23 May 2025
MICHAEL PATRICK MILLER Director $8,009 01 Feb 2026

Recent Insider Transactions by Companies or Individuals for RIGEL PHARMACEUTICALS INC

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.